Cullen/Frost Bankers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Sell
35,464
-147
-0.4% -$12.9K 0.03% 246
2026
Q1
$3.04M Buy
35,611
+7,588
+27% +$676K 0.03% 244
2025
Q4
$2.21M Buy
28,023
+710
+3% +$55.7K 0.02% 271
2025
Q3
$2.18M Sell
27,313
-585
-2% -$49.9K 0.03% 259
2025
Q2
$2.54M Sell
27,898
-368
-1% -$33.6K 0.03% 235
2025
Q1
$2.65M Sell
28,266
-93
-0.3% -$8.33K 0.04% 231
2024
Q4
$2.58M Sell
28,359
-1,105
-4% -$105K 0.04% 228
2024
Q3
$3.06M Sell
29,464
-1,638
-5% -$167K 0.04% 218
2024
Q2
$3.02M Sell
31,102
-508
-2% -$46.9K 0.04% 219
2024
Q1
$2.85M Sell
31,610
-464
-1% -$39.3K 0.04% 223
2023
Q4
$2.56M Buy
32,074
+436
+1% +$32.8K 0.04% 225
2023
Q3
$2.25M Sell
31,638
-938
-3% -$70.1K 0.04% 232
2023
Q2
$2.51M Sell
32,576
-2,937
-8% -$227K 0.04% 230
2023
Q1
$2.67M Sell
35,513
-1,635
-4% -$122K 0.05% 226
2022
Q4
$2.93M Buy
37,148
+2,661
+8% +$200K 0.06% 214
2022
Q3
$2.42M Sell
34,487
-127
-0.4% -$9.96K 0.06% 215
2022
Q2
$2.77M Sell
34,614
-512
-1% -$40K 0.06% 211
2022
Q1
$2.66M Sell
35,126
-239
-0.7% -$18.9K 0.05% 222
2021
Q4
$3.02M Sell
35,365
-3,100
-8% -$242K 0.06% 214
2021
Q3
$2.91M Sell
38,465
-278
-0.7% -$22.1K 0.06% 218
2021
Q2
$3.15M Hold
38,743
0.06% 215
2021
Q1
$3.05M Sell
38,743
-4,419
-10% -$346K 0.07% 213
2020
Q4
$3.69M Sell
43,162
-7,631
-15% -$631K 0.09% 184
2020
Q3
$3.92M Sell
50,793
-7,640
-13% -$583K 0.1% 174
2020
Q2
$4.28M Buy
58,433
+14,607
+33% +$1.04M 0.11% 172
2020
Q1
$2.91M Sell
43,826
-1,356
-3% -$95.6K 0.1% 175
2019
Q4
$3.11M Sell
45,182
-2,446
-5% -$167K 0.09% 195
2019
Q3
$3.5M Sell
47,628
-1,438
-3% -$104K 0.1% 174
2019
Q2
$3.52M Sell
49,066
-1,012
-2% -$71.8K 0.11% 170
2019
Q1
$3.43M Buy
50,078
+638
+1% +$41.2K 0.11% 167
2018
Q4
$2.94M Sell
49,440
-445
-0.9% -$27.8K 0.11% 170
2018
Q3
$3.34M Sell
49,885
-2,258
-4% -$150K 0.1% 170
2018
Q2
$3.38M Sell
52,143
-155
-0.3% -$10.1K 0.1% 169
2018
Q1
$3.75M Sell
52,298
-2,108
-4% -$152K 0.11% 164
2017
Q4
$4.11M Sell
54,406
-1,556
-3% -$114K 0.13% 158
2017
Q3
$4.08M Sell
55,962
-4,246
-7% -$306K 0.13% 158
2017
Q2
$4.46M Sell
60,208
-2,902
-5% -$215K 0.15% 155
2017
Q1
$4.62M Sell
63,110
-6,442
-9% -$451K 0.16% 146
2016
Q4
$4.55M Sell
69,552
-1,789
-3% -$123K 0.16% 150
2016
Q3
$5.29M Sell
71,341
-3,851
-5% -$285K 0.19% 137
2016
Q2
$5.5M Sell
75,192
-1,707
-2% -$122K 0.2% 126
2016
Q1
$5.43M Sell
76,899
-4,285
-5% -$285K 0.2% 123
2015
Q4
$5.41M Sell
81,184
-2,071
-2% -$138K 0.2% 126
2015
Q3
$5.28M Sell
83,255
-1,263
-1% -$82.5K 0.21% 121
2015
Q2
$5.53M Sell
84,518
-2,838
-3% -$193K 0.21% 126
2015
Q1
$6.06M Sell
87,356
-1,057
-1% -$73.1K 0.23% 122
2014
Q4
$6.12M Sell
88,413
-520
-0.6% -$35.1K 0.24% 126
2014
Q3
$5.8M Buy
88,933
+775
+0.9% +$51.1K 0.23% 121
2014
Q2
$6.01M Sell
88,158
-173
-0.2% -$11.6K 0.24% 122
2014
Q1
$5.73M Buy
88,331
+2,795
+3% +$176K 0.25% 119
2013
Q4
$5.58M Buy
85,536
+4,704
+6% +$301K 0.25% 121
2013
Q3
$4.79M Buy
80,832
+1,002
+1% +$59.4K 0.23% 128
2013
Q2
$4.57M Buy
+79,830
New +$4.74M 0.24% 126

Other funds holding CL

Cullen/Frost Bankers's CL Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Colgate-Palmolive (CL) stake by 0.41% in Q2 2026, selling an estimated $12.9K and leaving 35,464 shares worth $3.25M. The position accounts for 0.03% of the portfolio, ranked #246.

Cullen/Frost Bankers first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.12M in Q4 2014. 650 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cullen/Frost Bankers held 35,464 shares of Colgate-Palmolive worth $3.25M as of Q2 2026.
  • Cullen/Frost Bankers sold 147 Colgate-Palmolive shares in Q2 2026, an estimated $12.9K.
  • Colgate-Palmolive made up 0.03% of Cullen/Frost Bankers's portfolio in Q2 2026, its #246 holding.
  • Cullen/Frost Bankers first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's Colgate-Palmolive position peaked at $6.12M in Q4 2014.
  • 650 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.